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Abstract
Rationale Disturbances in impulse control are key features
of substance abuse disorders, and conversely, many drugs
of abuse are known to elicit impulsive behavior both
clinically and preclinically. To date, little is known with
respect to the involvement of the opioid system in
impulsive behavior, although recent findings have demon-
strated its involvement in delay discounting processes. The
aim of the present study was to further investigate the role
of the opioid system in varieties of impulsivity.
Materials and methods To this end, groups of rats were
trained in the five-choice serial reaction time task (5-
CSRTT) and stop-signal task (SST), operant paradigms that
provide measures of inhibitory control and response
inhibition, respectively. In addition, another group of rats
was trained in the delayed reward paradigm, which
measures the sensitivity towards delay of gratification and
as such assesses impulsive choice.
Results and discussion Results demonstrated that mor-
phine, a selective µ-opioid receptor agonist, primarily
impaired inhibitory control in the 5-CSRTT by increasing
premature responding. In addition, in keeping with previous
data, morphine decreased the preference for the large over
small reward in the delayed reward paradigm. The effects
of morphine on measures of impulsivity in both the 5-
CSRTT and delayed reward paradigm were blocked by
naloxone, a µ-opioid receptor antagonist. Naloxone by
itself did not alter impulsive behavior, suggesting limited
involvement of an endogenous opioid tone in impulsivity.
Response inhibition measured in the SST was neither
altered by morphine nor naloxone, although some
baseline-dependent effects of morphine on response inhibi-
tion were observed.
Conclusion In conclusion, the present data demonstrate that
acute challenges with morphine modulate distinct forms of
impulsive behavior, thereby suggesting a role for the opioid
system in impulsivity.
Keywords Cognition . Inhibitory control .
Impulsive choice .Morphine . Naloxone
Introduction
A commonly observed effect of many substances of abuse
and in particular psychostimulants such as amphetamine,
cocaine, and nicotine is that they impair behavioral inhibition
and increase impulsivity in humans (Fillmore et al. 2002;
Mitchell 2004) as well as laboratory animals (Cole and
Robbins 1987, 1989; Harrison et al. 1997; Paine and
Olmstead 2004; Van Gaalen et al. 2006a). Furthermore, a
wealth of findings have demonstrated that chronic psychos-
timulant abuse is associated with a variety of cognitive
disturbances including elevated levels of impulsivity (e.g.,
Clark et al. 2006; Coffey et al. 2003; Ersche et al. 2008;
Kirby and Petry 2004; Monterosso et al. 2005; Verdejo-
Garcia et al. 2007; for review, see Perry and Carroll 2008).
However, somewhat contradictory findings have been
reported in laboratory animals depending on forced
(Jentsch et al. 2002; Paine et al. 2003; Simon et al. 2007)
or volitional administration of psychostimulant drugs (Dalley
et al. 2005a, b, 2007; but see, Winstanley et al. 2009).
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To date, the effects of opioid drugs on impulsivity have
been less well documented, although recent evidence points
towards a role for the opioid system in impulsivity. For
instance, abstinent alcoholics have been shown to make
impulsive decisions in a delay discounting task (Mitchell et al.
2005), operationalized as a preference for smaller and sooner
over larger and later hypothetical monetary reward. Interest-
ingly, in these subjects, the opioid receptor antagonist
naltrexone reduced impulsive decisions in this task depend-
ing on the subjects' locus of control personality trait
(Mitchell et al. 2007). Also, in control subjects, naltrexone
improved performance on a measure of inhibitory motor
control in this task. Collectively, these findings suggest that
opioid activity might modulate aspects of impulsive behav-
ior. In support of this, in rats, acute challenges with the μ-
opioid receptor agonist morphine induce impulsive decisions
in an adjusting amount procedure (Kieres et al. 2004) and
seem to induce delay aversion in a delay discounting task
(Pitts and McKinney 2005). Thus, these observations
confirm a role for µ-opioid receptors in impulsive decision
making.
In addition to the aforementioned acute opioid drug
challenges on measures of impulsivity, several studies have
reported increased risky decision making (Odum et al.
2000), as well as impulsive decision making in opiate users
(Clark et al. 2006; Madden et al. 1997; Petry et al. 1998;
Kirby and Petry 2004). To date, there is little evidence of
chronic opiate use on perturbations in measures of
inhibitory response control (Verdejo-Garcia and Perez-
Garcia 2007; Verdejo-Garcia et al. 2007; Passetti et al.
2008). In contrast to acute opioid effects on impulsivity,
elevated impulsivity in opiate addicts might also have
resulted from neuroadaptations following prolonged opiate
use. In this regard, alterations in brain opioid and α2
adrenergic receptor densities have been reported in opiate
addicts (Gabilondo et al. 1994; Kling et al. 2000). Studying
the acute effects of opioids on impulsivity might help to
interpret the aforementioned observations in opiate addicts.
There is broad consensus that impulsivity is multifacto-
rial with distinct behavioral expressions that might be under
control of partly separate underlying neuroanatomical
circuits and neurotransmitter systems (Evenden 1999; Pattij
and Vanderschuren 2008; Winstanley et al. 2006). Poor
inhibitory response control (impulsive action) and impul-
sive decision making (impulsive choice) are prominent
behavioral phenomena of impulsivity, the latter often
operationalized as delay aversion in delay discounting
tasks. The aforementioned observations primarily suggest
a role for the opioid system in impulsive decision making.
Therefore, the purpose of the present experiments was to
further examine the role of μ-opioid receptors in distinct
forms of impulsive behavior. To this extent, we investigated
the acute effects of morphine and naloxone in three
translational rodent paradigms: (1) the five-choice serial
reaction time task (5-CSRTT; Bari et al. 2008) to measure
aspects of inhibitory response control, reflected by the
ability to withhold inappropriate responses; (2) the stop-
signal task (Eagle et al. 2008) to measure response
inhibition, i.e., the ability to inhibit a response that already
has been initiated; and (3) the delayed reward paradigm
(Cardinal 2006) to measure delay aversion.
Materials and methods
Subjects
Male Wistar rats were obtained from Harlan CPB (Horst,
The Netherlands). At the start of the experiments, animals
were 12 weeks old, weighed approximately 250 g, and
were housed in pairs in macrolon cages (42.5×26.6×
18.5 cm; l×w×h) under a reversed 12-h light/dark cycle
(lights on at 7:00P.M.) at controlled room temperature (21±
2°C) and relative humidity of 60±15%. Animals were
maintained at approximately 90% of their free-feeding
weight, starting 1 week prior to the beginning of the
experiments by restricting the amount of standard rodent
food pellets (Harlan Teklad Global Diet, Blackthorn, UK).
Water was available ad libitum throughout the entire
experiment. All experiments were conducted with the
approval of the animal ethical committee of the Vrije
Universiteit, Amsterdam, The Netherlands.
Apparatus
Experiments were conducted in identical rat five-hole nose
poke operant chambers with stainless steel grid floors
(MED-NPW-5L, Med Associates, St. Albans, VT, USA)
housed in sound-insulating and ventilated cubicles. Set in
the curved wall of each box was an array of five holes.
Each nose poke unit was equipped with an infrared detector
and a yellow light emitting diode stimulus light. Rodent
food pellets (45 mg, Formula P, Bioserv, Frenchtown,
USA) could be delivered at the opposite wall via a
dispenser. In addition, a white house light could illuminate
the chamber and a 4,500-Hz tone could be delivered
through a speaker. A computer equipped with MED-PC
version 1.17 (Med Associates) controlled experimental
sessions and recorded data. Animals were tested once daily
from Monday until Friday, during the dark phase of the
light/dark cycle.
Behavioral procedures
Separate groups of n=16 animals were trained for all
paradigms for which similar habituation and magazine
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training protocols were followed. This protocol consisted of
a habituation exposure to the operant chambers for 20 min
with the houselight on and the food cup containing three
food pellets for two consecutive sessions. Subsequently, in
the next two sessions, pellets (100 per session) were
delivered with an average delay of 15 s to allow the
animals to associate the sound of pellet delivery with
reward.
Five-choice serial reaction time task experiments
A detailed description of the 5-CSRTT behavioral
procedure in our laboratory has been provided previ-
ously (Van Gaalen et al. 2006a). In short, rats were
trained to detect and respond to a brief visual stimulus in
one of five nose poke units in order to obtain a food
reward. Each session terminated after 100 trials or 30 min,
whichever occurred first. Initially, the duration of this
stimulus was 32 s and was gradually decreased to 1 s over
sessions until animals reached stable baseline performance
(accuracy >80% correct choice and <20% errors of
omission). Responding during stimulus presentation or
within the limited hold (LH) period of 2 s was counted as
a correct response. Incorrect, premature responses during
the fixed 5-s intertrial interval and errors of omission (no
responses or a response after the LH) did not lead to the
delivery of a food reward and resulted in a 5-s timeout
period during which the houselight was extinguished,
whereas perseverative responses, i.e., repeated responding
during the presentation of the stimulus, were measured but
did not have any programmed consequences. Two differ-
ent measures of inhibitory control were measured, namely,
(1) the number of premature responses before the onset of
the visual stimulus, reflecting aspects of loss of inhibitory
control and (2) the number of perseverative responses into
the stimulus unit after correct choice, a measure of
compulsive behavior. In addition, the following other
behavioral parameters were measured that reflect task
performance, namely, (3) accurate choice, i.e., percentage
correct responses calculated as [number correct trials/
(correct+incorrect trials)] × 100; (4) latency to make a
correct choice, i.e., the mean time between stimulus onset
and nose poke in the illuminated unit; (5) omission errors,
i.e., the number of omitted trials during a session; and (6)
feeder latency, i.e., the latency to collect a pellet following
correct choice.
Stop-signal task experiments
Training A detailed description of training in the stop-
signal task in our laboratory has been provided
previously with some minor modifications in the current
behavioral procedure (Pattij et al. 2007a). In the current
study, the outer nose poke units were used instead of those
immediately adjacent to the middle nose poke unit as
described previously. In terms of behavioral performance,
this modification primarily resulted in higher mean
reaction times, and therefore, stop-signal delays (SSD)
were also adjusted accordingly as described below. In
brief, rats were trained in the same boxes used in the 5-
CSRTT experiments and a typical stop-signal task session
consisted of 200 trials; 25% of these trials were stop trials
and the remainder go trials. To start a go trial, rats were
trained to respond into the middle illuminated nose poke
unit stimulus light (start stimulus) under a variable ratio 2
schedule which subsequently switched off this stimulus
light and resulted into illumination of the outer left (or
right, counterbalanced across rats) nose poke unit stimulus
light (go stimulus). Rats were then required to respond as
quickly as possible during a LH period to this go stimulus
in order to obtain a food reward. Initially, the LH period
was set at 5 s and in subsequent sessions was
individually titrated to meet go-trial accuracy criterion
of approximately 80% successful hits. A stop trial did
not differ from a go trial; however, contingent with the
illumination of the go stimulus or following a SSD, a
stop signal (duration 50 ms; frequency 4500 Hz;
intensity 80 dB) was presented and successfully refrain-
ing from responding during the LH period of a stop
trial resulted in delivery of a food reward. In the final
stages of training, the LH periods during both go and stop
trials were equal for each individual rat. The SSDs including
zero delays were presented in a pseudorandom order within a
session. To compensate for differences between rats, SSDs
were based on each individual rat's mean reaction time on go
trials (mGoRT) in the preceding drug-free training session.
Thus, SSDs were calculated as follows: mGoRT minus either
25, 75, 150, 300, or 600 ms. During all stop trials,
responding during the onset of the stop signal or during the
LH immediately extinguished the go stimulus, houselight,
and, if applicable, turned off the stop signal and was
followed by a 5-s timeout period.
Estimation stop-signal reaction time Calculations to esti-
mate the stop-signal reaction times (SSRT) and a
correction for omission errors were adapted from Logan
(1994) and Solanto et al. (2001). For estimating the SSRT,
data of three SSDs (mRT minus 300, 150, and 75 ms)
were used, as the probability of correct inhibition on these
SSDs was within the range of 0.2<p<0.8 and thus most
informative for estimation of SSRT (Band et al. 2003). For
each of the three SSDs, the probability of responding was
calculated including a correction for non-responses
based on the number of omissions during the go trials,
the latter since omissions cannot be distinguished from
successful inhibitions during stop trials. The following
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formula, adapted from Solanto et al. (2001), was used for
these calculations:
p respondingð Þ ¼ x correct inhibitionsð Þ= x xyð Þj j;
where x is the number of stop-signal trials at each delay
interval; correct inhibitions are the number of correctly
inhibited trials and y is the probability of omissions during
the go trials within the entire session. To calculate SSRTs,
reaction times on all go trials were rank-ordered. From this
list with RTs, the “nth” RT was taken, where “n” was
obtained by multiplying the total number of go trials by the
probability of responding for a particular SSD. This RT
value approximates the latency between onset of the go
stimulus and completion of the stopping process. The SSRT
for each interval is then obtained by subtracting the SSD
interval from this RT. The average estimated SSRT that is
used for the analyses in the present study is calculated by
taking the mean of each SSRT at the aforementioned three
SSDs.
Delayed reward paradigm experiments
The delayed reward paradigm used in our laboratory has
been described previously (Van Gaalen et al. 2006b).
Briefly, in the final stages of training and during drug
testing, a session was divided into five blocks of 12 trials,
each block started with two forced choice trials. Each rat
received a left forced and a right forced trial. The order of
these was counterbalanced between subjects. In the next ten
trials, the animals had a free choice and both the left and
right unit were illuminated. Poking into one position
resulted in the immediate delivery of a small reinforcer
(one food pellet), whereas a nose poke into the other
position resulted in the delivery of a large, but delayed,
reinforcer (four food pellets). If an animal did not make a
response during this choice phase within 10 s, an intertrial
interval was initiated and the trial was counted as an
omission. The position associated with the small and large
reinforcer was always the same for each individual and
counterbalanced for the group of rats. Delays for the large
reinforcer progressively increased within a session per
block of 12 trials as follows: 0, 5, 10, 20, and 40 s.
Responding into non-illuminated units during the test was
recorded, but had no further programmed consequences.
The behavioral measure to assess task performance, i.e., the
percentage preference for the large reinforcer as a function
of delay, was calculated as the number of choices for the
large reinforcer/(number choices large+small reinforcers) ×
100. Furthermore, we calculated the total number of
omitted choice trials per block of ten trials within a session.
In addition to the percentage preference data, hyperbolic
curves were fitted by employing the least-squares criterion
on individual data obtained in the drug studies using
GraphPad Prism version 5 (GraphPad Software, La Jola,
CA, USA). The following equation from Mazur (1987) was
used: Y ¼ A=1þ kD, where Y is the mean percentage
preference for the large reinforcer, D is the delay to obtain
the large reinforcer, A is a free parameter related to the
amount of reinforcement, and k is free parameter indicating
the steepness of the discounting curve.
Drugs
Morphine hydrochloride (OPG, Utrecht, The Nether-
lands) and naloxone hydrochloride (Sigma, St. Louis,
MO, USA) were dissolved in sterile saline. Drug doses
were based on a previous study investigating the effects
of morphine and naloxone on an operant progressive
ratio schedule (Solinas and Goldberg 2005). In all
experiments, drugs were injected 30 min before testing,
whereas in drug combination studies, naloxone was
injected 30 min and morphine was injected 20 min prior
to testing. Drugs were freshly prepared each day before
testing and intraperitoneally injected in a volume of
1-ml/kg bodyweight according to a Latin square within-
subjects design for both the dose–response studies as
well as the drug combination studies on Tuesdays and
Fridays with baseline training sessions on the other
weekdays.
Statistical analyses
Data were subjected to repeated measures analysis of
variance with drug dose (all paradigms) and delay to large
reinforcer (delayed reward paradigm only) as within-
subjects variables using the Statistical Package for the
Social Sciences version 14 (SPSS, Chicago, IL, USA). The
homogeneity of variance across groups was determined
using Mauchly's tests for equal variances, and in case of
violation of homogeneity, Huynh–Feldt epsilon (ε) adjusted
degrees of freedom were applied and the resulting more
conservative probability values depicted and used for
subsequent analyses. In case of statistically significant main
effects, further post hoc comparisons were conducted using
Newman–Keuls multiple comparison tests. The level of
probability for statistically significant effects was set at
0.05. In the delayed reward experiments, the highest dose
of morphine (6.0 mg/kg) increased choice for the small
reward at 0-s delays. Therefore, the delay discounting
curves in the morphine/ naloxone combination study were
also analyzed as percentage change in preference from the
0-s delay in order to control for these baseline differences.
In the stop-signal task, Pearson's correlation coefficients
were also calculated in order to explore the relationship
between the magnitude of drug effects, i.e., change in SSRT
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from vehicle to drug (morphine, naloxone) and baseline
SSRT under vehicle condition.
Results
Effects of morphine on impulsive action in the five-choice
serial reaction time task
As depicted in Fig. 1a, c and Table 1, under stable baseline
responding, morphine significantly increased the number of
premature responses and decreased the number of persev-
erative responses after correct choice [F(4,60)=4.14, ε=
0.46, p=0.030 and F(4,60)=4.15, ε=0.67, p=0.015, re-
spectively]. Further comparisons indicated that 3.0 and
6.0 mg/kg morphine significantly increased the number of
premature responses, whereas only 6.0 mg/kg morphine
decreased the number of perseverative responses. In
addition to increasing impulsive action, the highest dose
of morphine also significantly increased the number of
omissions [F(4,60)=14.32, ε=0.65, p<0.001] and in-
creased correct response latencies [F(4,60)=4.29, ε=0.60,
p=0.016]. Attentional performance measured by the per-
centage accurate choice was not affected by morphine [F
(4,60)=1.09, p=0.37 and F(4,60)=2.17, ε=0.42, p=0.10].
Likewise, the latency to collect food reward after correct
Fig. 1 Effects of morphine
(a, b), naloxone (c, d), and their
combination (e, f) on different
measures of inhibitory control in
the 5-CSRTT. In total, n=16
(a–d) and n=15 (e, f) animals
were included in the analyses
and data depict mean (±SEM)
numbers of premature responses
(a, c, e) and perseverative
responses after correct choice
(b, d, f). *p<0.05 versus vehicle
and vehicle–vehicle (0–0) injec-
tions and +p<0.05, ++p<0.005
versus vehicle/3.0 mg-kg
morphine injections
Psychopharmacology (2009) 205:489–502 493
choice was not significantly changed by morphine [F(4,60)=
2.67, ε=0.40, p=0.10].
The effects of naloxone on performance in the 5-CSRTT
are summarized in Fig. 1b, d and Table 1. Naloxone
increased correct response latencies [F(3,45)=4.59, p=
0.007], and further comparisons revealed that only the
highest dose significantly increased latencies by approxi-
mately 20 ms. In addition, the lowest dose of 0.3 mg/kg
naloxone significantly reduced the number of perseverative
responses after correct choice [F(3,45)=2.96, p=0.042].
Other performance measures in the 5-CSRTT reflecting
impulsive action, attentional performance, and motivation
were not affected by naloxone [accurate choice: F(3,45)=
0.60, p=0.62; premature responses: F(3,45)=2.46, p=
0.075; omissions: F(3,45)=0.26, ε=0.81, p=0.81; feeder
latency: F(3,45)=1.28, ε=0.43, p=0.29].
In the morphine/naloxone combination study (morphine
3.0 mg/kg and naloxone 0.3 and 1.0 mg/kg), one animal
was excluded from the analyses due to high number of
omissions displayed by this animal on two different test
days (68 and 72 omissions, respectively). The effects of
3.0 mg/kg morphine on impulsive action in the 5-CSRTT
were fully antagonized by both doses of naloxone (Fig. 1e)
[F(3,42)=6.98, ε=0.66, p=0.004]. Likewise, 0.3 and
1.0 mg/kg naloxone blocked the small but significant
increase in the number of omissions by 3.0 mg/kg
morphine [F(3,42)=3.44, ε=0.77, p=0.038]. In contrast to
the morphine alone study, in the combination study, 3.0 mg/kg
morphine slightly but significantly decreased the number of
perseverative responses after correct choice from approxi-
mately seven to five responses, which was antagonized by
both doses naloxone (Fig. 1f) [F(3,42)=5.78, p=0.002]. In
addition, in the combined morphine/ naloxone experiments,
morphine significantly speeded the latency to collect food
reward after correct choice, and these effects of morphine
were antagonized by both doses of naloxone [F(3,42)=
18.34, p<0.001]. Attentional parameters in the 5-CSRTT
were not altered by the combination of morphine and
naloxone [accurate choice: F(3,42)=2.26, p=0.095; correct
response latency: F(3,42)=0.49, p=0.69].
Effects of morphine on response inhibition
in the stop-signal task
In the stop-signal task experiments, one animal was
excluded from all analyses because it did not acquire stable
performance. Moreover, two additional animals were
excluded from all analyses because of their low go trial
accuracy and high omission rate of around 50% of all go
trials during training and test sessions.
Morphine did not alter the estimated SSRT, the primary
measure of response inhibition, and, in addition, mGoRTs
were also not changed by morphine (Fig. 2 a, c) [F(3,36)=
0.76, p=0.52 and F(3,36)=2.54, ε=0.63, p=0.10, respec-
tively]. Only the high dose of 3.0 mg/kg morphine did,
however, significantly affect behavior during the go trials
and decreased go trial accuracy from 77% under vehicle
conditions to 57% [F(3,36)=6.17, ε=0.55, p=0.012].
Further inspection of the data revealed that this decrease
was primarily caused by two rats displaying a go trial
accuracy of 17% and 21%, respectively, only at the high
(3.0 mg/kg) dose morphine. In order to explore whether
morphine had differentially affected response inhibition
depending on baseline SSRT under vehicle condition, a
correlation analysis was performed. This analysis revealed
that the effect size of morphine on SSRT (averaged over the
Accuracy (%) Response latency (ms) Omissions (%) Feeder latency (ms)
MOR
Vehicle 87.1±1.3 289±7 7.9±1.8 769 ±27
0.3 mg/kg 87.0±1.3 307±9 8.1±1.6 853±93
1.0 mg/kg 85.7±1.6 303±15 11.3±3.5 732±27
3.0 mg/kg 85.8±1.8 320±13 17.6±5.0 696±29
6.0 mg/kg 88.7±1.5 358±24* 35.8±5.9** 695±36
NAL
Vehicle 87.7±1.5 293±7 12.5±4.1 823±53
0.3 mg/kg 87.4±1.2 290±8 11.8±3.4 760±29
1.0 mg/kg 89.1±1.3 300±8 9.5±1.4 795±28
3.0 mg/kg 88.8±1.3 316±8* 11.1±1.5 792±27
NAL+3.0 mg/kg MOR
Vehicle–vehicle 86.8±1.3 294±7 5.3±1.1 727±20
Vehicle–MOR 85.2±1.2 292±5 10.4±1.4*** 637±20****
0.3 mg/kg–MOR 87.6±1.1 300±8 6.0±1.3 725±23
1.0 mg/kg–MOR 88.8±1.4 290±9 7.1±1.0 732±22
Table 1 Effects of morphine
(MOR), naloxone (NAL) and
their combination on measures
of attentional function and mo-
tivation in the 5-CSRTT
In total, n=16 animals were
included in the analyses and
data depict mean±SEM
*p<0.05, **p<0.005 (versus
vehicle); ***p<0.05, ****p<
0.005 (compared to vehicle/ve-
hicle and NAL/MOR drug com-
binations)
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three doses 0.3, 1.0, and 3.0 mg/kg) correlated nega-
tively with baseline SSRT as shown in Fig. 2e (Pear-
son’s r=−0.83, p<0.001). The effect size of morphine on
mGoRT did, however, not correlate with baseline SSRT
(data not shown; Pearson’s r=−0.32, p=0.23).
Comparable to the effects of morphine, naloxone did
neither affect estimated SSRTs nor mGoRTs (Fig. 2b, d) [F
(3,36)=0.69, p=0.56 and F(3,36)=2.73, p=0.058, respec-
tively]. Furthermore, naloxone had no effects on go trial
accuracy [F(3,36)=0.39, p=0.76]. In contrast to the effects
of morphine, there was no relationship between the effects
of naloxone on response inhibition and baseline SSRT
(Pearson’s r=−0.36, p=0.089).
Effects of morphine on impulsive choice in the delayed
reward paradigm
The percentage choice for the larger delayed reward
significantly declined depending on the delay that was
imposed on the animals (Fig. 3a) [delay: F(4,60)=156.15,
p<0.001]. Morphine significantly reduced the preference
for the large delayed reward [dose: F(4,60)=3.35, ε=0.64,
p=0.035; dose×delay: F(16,240)=1.58, p=0.082], and
further, post hoc comparisons revealed that this effect was
significant in the highest dose morphine. However, analyses
of the steepness (k) of the discounting curves with
morphine revealed no significant differences between
Fig. 2 Effects of morphine and
naloxone on response inhibition
as measured in the stop-signal
paradigm. In total, n=13 ani-
mals were included in the mor-
phine and naloxone analyses
and data are depicted as mean
(±SEM) estimated stop-signal
reaction times (a, b) and go
reaction times (c, d). In addition,
Pearson’s r indicated a negative
correlation between the magni-
tude morphine’s effects on
SSRT averaged over all three
doses and baseline SSRT under
vehicle condition (e). *p<0.05
versus vehicle
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doses, thereby supporting the lack of a dose×delay
interaction effect [F(4,60)=1.40, ε=0.25, p=0.26]. The
number of omissions to start a trial (range, 1.03±0.23 to
1.67±0.35 omissions/block) was not significantly affected
by morphine [dose: F(4,60)=1.71, p=0.16; dose×delay: F
(16,240)=1.22, p=0.25]. It should be noted that in two
individuals, 6.0 mg/kg morphine did bias choice towards
one response option irrespective of the delay. One animal
preferably chose the response alternative associated with
the immediate small reward, whereas the other mainly
preferred the delayed large reward. All other rats displayed
a delay-dependent decrease in preference for the large
reward at this dose of morphine, although the majority did
show a modest reduction in choice for the large reward at
the 0-s delay with 6.0 mg/kg morphine. Excluding these
two individuals with biased choice from the analyses did
not alter the main findings with morphine [dose: F(4,52)=
2.72, p=0.039; dose×delay: F(16,208)=1.05, p=0.40].
Naloxone slightly but significantly shifted the preference
for the larger delayed reward (Fig. 3b) [dose: F(3,45)=0.46,
p=0.71; dose×delay: F(12,180)=2.04, ε=0.66, p=0.048].
However, further comparisons revealed no significant
dose×delay interaction effects of naloxone at any dose
compared with vehicle. This suggests that the overall
dose×delay interaction effect lacks biological significance.
Further analyses of the steepness of the discounting curves
supported this notion [F(3,45)=1.19, ε=0.44, p=0.31].
Similarly, naloxone did not affect the number of omissions
to start a trial [dose: F(3,45)=2.28, ε=0.65, p=0.12; dose×
delay: F(12,180)=1.07, p=0.39].
In the combination study (Fig. 3c), the effects of
6.0 mg/kg morphine were antagonized by naloxone [dose:
F(3,45)=4.63, ε=0.74, p=0.014; dose×delay: F(12,180)=
2.62, ε=0.93, p=0.004], and further comparisons showed
that this was the case for 1.0 mg/kg naloxone. This
significant dose×delay interaction effect was further sub-
stantiated by the slope analysis of the discounting curves [F
(3,45)=2.91, ε=0.51, p=0.045] which revealed significant
differences in steepness of the slopes between vehicle–
vehicle versus vehicle–morphine and 0.3 mg/kg naloxone–
morphine. Similar to the morphine dose–response
experiment, one individual always preferred the response
alternative associated with the immediate small reward.
Excluding this individual from the analyses did not change
the main findings [dose: F(3,42)=3.77, ε=0.71, p=0.032;
dose×delay: F(12,168)=2.46, ε=0.89, p=0.008].
Fig. 3 Effects of morphine (a),
naloxone (b), and their combi-
nation (c) on the mean percent-
age preference for the large
reinforcer and change in prefer-
ence from the 0-s delay (d) in
the delayed reward paradigm.
In total, n=16 animals were
included in the analyses. SED
standard error of differences
between means. *p<0.05 versus
vehicle/vehicle and +p <0.05
versus vehicle/6.0-mg/kg
morphine injections
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To control for the decrease in preference for the large
reward that occurred with 6.0 mg/kg morphine at the 0-s
delay, further analyses were performed. To this end, all data
from the morphine/naloxone combination study were also
calculated as percentage change in preference from the 0-s
delay (Fig. 3d). Analyses on these data revealed that
morphine significantly shifted the preference for the large
reward depending on the delay [dose: F(3,45)=1.79, ε=
0.71, p=0.18; dose×delay: F(12,180)=2.40, ε=0.81, p=
0.012]. These effects of morphine on the preference for the
large reward depending on the delay were reversed by
1.0 mg/kg naloxone.
Discussion
The main findings of the present study are that acute
challenges with morphine modulate impulsive behavior, as
expressed in impaired inhibitory response control and—to a
somewhat lesser extent—impulsive decisions. The number
of premature responses in the 5-CSRTT was dose-
dependently increased following morphine, and in addition,
morphine also biased the preference from larger more
beneficial delayed rewards towards small and immediate
rewards. The observation that the effects of morphine were
abolished by naloxone strongly suggests μ-opioid receptor
involvement in different forms of impulsive behavior. In
contrast, morphine did not change response inhibition as
measured in the stop-signal task, although in a correlation
analysis, baseline-dependent effects of morphine on re-
sponse inhibition were detected and morphine seemed to
improve response inhibition in rats with “slow” stopping
abilities. In the absence of an effect of naloxone on the
different forms of impulsive behavior, our data do not
provide clear evidence for a role of tonically activated
μ-opioid receptors by endogenous opioids in measures of
impulsivity. In as much as these observations can be
extrapolated to clinical data, they do not support the
recently reported beneficial effects of a single dose of
naltrexone in healthy volunteers on a measure of inhibitory
response control (Mitchell et al. 2007). However, in that
study, the effects of naltrexone (50 mg) on inhibitory
response control were derived from a calculated measure in
a delay discounting task and not from results obtained in a
separate task measuring inhibitory response control, which
may have accounted for this discrepancy in findings.
The observation that morphine robustly increased
premature responding in the 5-CSRTT extends previous
reported acute effects of psychostimulants such as
amphetamine, cocaine, and nicotine on impulsive action
(Cole and Robbins 1987, 1989; Evenden 1998; Harrison
et al. 1997; Paine and Olmstead 2004; Pattij et al. 2007b;
Van Gaalen et al. 2006a). Strikingly, the high dose of
morphine (6.0 mg/kg) was found to improve a different
measure of inhibitory response control in this paradigm by
reducing the number of perseverative responses following
correct choice and before food reward collection (see for
review, Robbins 2002). This finding may suggest benefi-
cial effects of morphine on aspects of compulsive
behavior. However, this dose of morphine also strongly
increased the number of omissions and lengthened
response latencies, and therefore, these effects on persev-
erative responding are likely due to non-specific drug
effects on motor behavior. In contrast to the effects of
morphine on measures of inhibitory control, other param-
eters in the 5-CSRTT reflecting attentional performance,
such as accurate choice, were not affected by morphine.
These latter findings are supported by recent observations
showing that morphine in a similar dose range did not
influence measures of sustained attention in a modified 5-
CSRTT with a stimulus duration of 5 s and a test session
consisting of 250 trials (Boyette-Davis et al. 2008).
To date, clinical evidence demonstrating inhibitory
response control deficits in opiate abusers is only scarcely
available. While the majority of these studies do not find
clear behavioral evidence of inhibitory response control
disturbances in opiate addicts (Passetti et al. 2008;
Verdejo-Garcia and Perez-Garcia 2007; Verdejo-Garcia et
al. 2007), some changes in brain activation patterns
following a Go/NoGo task have been detected in opiate
users (Forman et al. 2004). Furthermore, a recent study
found evidence for reflection impulsivity in opiate users
(Clark et al. 2006), i.e., the tendency to act before all
necessary information is evaluated. Although reflection
impulsivity may conceptually be regarded as a separate
form of impulsive behavior (see for discussion, Evenden
1999), it might contain aspects of both deficient inhibitory
response control and impulsive decision making.
Consistent with the aforementioned paucity of evidence
demonstrating inhibitory control deficits in opiate users,
morphine had no clear effects on response inhibition as
measured in the stop-signal task. Thus, our stop-signal task
data suggest minor μ-opioid receptor involvement in the
ability to inhibit ongoing behavior and contrast the findings
in the 5-CSRTT. The latter task measures the ability to
withhold inappropriate (premature) responses, and clearly,
the opioid system modulates these inhibitory response
control processes. These observations add to the growing
literature demonstrating that the 5-CSRTT and stop-
signal task measure different cognitive processes that
can be dissociated neuroanatomically and pharmacolog-
ically (Eagle et al. 2008; Winstanley et al. 2006). Further
in-depth analyses on the stop-signal data revealed that the
effect size of morphine on estimated SSRT, the primary
parameter reflecting response inhibition, correlated nega-
tively with SSRTs under vehicle condition. Thus, in
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individuals with a low baseline SSRT and better stopping
abilities, morphine seemed to “impair” response inhibition
by increasing the SSRT. In contrast, in “slow” stopping
rats with higher baseline SSRTs, morphine seemed to
“improve” response inhibition by decreasing the SSRT.
These findings suggest baseline-dependent effects of
morphine on response inhibition that could not be detected
when the data were calculated over the entire population
of rats. This conclusion should be drawn with caution, as
we only explored such a relationship by correlation
analyses and did not preselect groups of individuals based
on response inhibition capacities. Notwithstanding this
limitation, various clinical and preclinical studies have
indeed supported this notion and shown that the behav-
ioral effects of, e.g., amphetamine, in healthy volunteers
(De Wit et al. 2000, 2002) as well as amphetamine and
methylphenidate in rats on response inhibition largely
seem to depend on baseline performance (Feola et al.
2000; Eagle et al. 2007).
The observation that morphine shifted more self-
controlled decisions by decreasing preference for the large
over small reward in our delayed reward paradigm is in
line with previous observations in rats (Kieres et al.
2004) and numerous findings of delay discounting in
opiate users (Clark et al. 2006; Madden et al. 1997; Petry
et al. 1998; Kirby and Petry 2004). With regard to these
observations in human opiate users, it is unclear whether
increased delay discounting in opiate users results from
premorbid levels of impulsive decision making or is the
consequence of chronic opiate abuse. Our findings and
those of Kieres et al. (2004) at least suggest acute effects
of opiates on impulsive decision making. While opiate
addicts generally discount the value of delayed monetary
rewards or the drug itself, in the present study, rats were
food-restricted and highly palatable food pellets served as
food reinforcement. Given the involvement of the central
opioid system in food reward, and in particular its
modulatory role on the hedonic properties of appetitive
foods (e.g., Solinas and Goldberg 2005; for review, see
Cota et al. 2006), it is possible that morphine might have
enhanced the hedonic property of the highly palatable
food pellets to the extent that rats shifted their preference
from larger delayed food reward to immediate reward.
Nonetheless, the finding that the number of omissions to
initiate a trial, a parameter that reflects aspects of food-
motivated behavior in the delayed reward paradigm
(Cardinal et al. 2000), did neither decrease following
morphine nor increase following naloxone argues against
such an explanation. Similarly, in the 5-CSRTT experi-
ments, neither morphine nor naloxone altered the primary
indices of food-motivated behavior, namely, the feeder
latency and number of omissions at doses that increased
impulsivity (Table 1).
It is important to emphasize that the highest morphine
dose modestly reduced the preference for the large reward
at the 0-s delay by approximately 15% compared to vehicle.
This observation may confound a solid interpretation of
morphine’s effects on impulsive choice. It is not entirely
clear what caused these effects, and this observation is not
unique to the present study. In previous experiments,
pharmacological challenges with, e.g., ethanol, the 5-
HT1A and 5-HT2 receptor agonists 8-OH-DPAT and DOI,
and the dopamine D1 receptor antagonist SCH23390 have
also been found to reduce the preference for the large
reward at the 0-s delay (Evenden and Ryan 1999; Van
Gaalen et al. 2006b; Winstanley et al. 2005). As discussed
above, effects on food-motivated behavior seem an unlikely
explanation, although positive reinforcing drugs including
morphine are known to possess aversive stimulus properties
and elicit conditioned taste aversions (Hunt and Amit
1987). The observation that following 6.0 mg/kg morphine
rats still earned and consumed a similar amount of pellets
compared to baseline training and vehicle conditions (data
not shown) argues against morphine-induced emetic effects.
Alternatively, it is possible that morphine caused difficulties
for the animals to distinguish between two behavioral
outcomes or induced a positional bias. However, if the
former is the case, the question remains why—on average
—this only applied to two out of ten choice trials at the 0-s
delay and did not result in chance performance throughout
the entire session. The finding that similar doses of
morphine did not induce a positional bias in the 5-CSRTT
(data not shown) does not support such an explanation.
Also, if morphine did bias the responses of the animals
towards one side of the operant chamber, one would expect
animals to always choose either the immediate small reward
or delayed large reward irrespective of the delay. Although
few individuals (n=2 in the morphine dose–response
experiment and n=1 in the morphine–naloxone experiment)
did indeed display biased responding with 6.0 mg/kg
morphine, excluding these individuals from the analyses
did not change the overall effects of morphine on delay
discounting. Importantly, all other animals highly preferred
the large reward at short delays and shifted their preference
with longer delays, although in the large majority of
animals, the preference for the large reward at the 0-s delay
was modestly reduced when treated with 6.0 mg/kg
morphine. Analyses on the steepness of the delay discount-
ing curves suggest that the effects of morphine became
stronger after repeated exposure. Whereas in the dose–
response study with morphine the slope of the delay
discounting curve with vehicle did not differ from
6.0 mg/kg, in the morphine–naloxone study, the steepness
of these curves did differ significantly. Although specu-
lative, perhaps tolerance to putative behavioral “disrup-
tive” effects of morphine at the 0-s delay explains these
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observations. Indeed, in a parallel study, we found that
repeated exposure to 6 mg/kg morphine appeared to
induce tolerance to this “disruptive” effect of the opiate
at the 0-s delay, whereas at larger delays, morphine still
significantly reduced preference for the larger reward.
Notwithstanding these possible confounds, the fact that
naloxone blocked morphine’s effects in the delayed
reward indicates a µ-receptor-dependent mechanism.
A possible mechanism of action by which morphine
might elevate impulsive behavior is through its modulatory
action on mesolimbic dopamine transmission. Opiates such
as heroin and morphine enhance dopamine transmission in
the nucleus accumbens (e.g., Di Chiara and Imperato 1986,
1988; Rada et al. 1991; Shoaib et al. 1995; Wise et al.
1995). These effects are primarily mediated through µ-
opioid-mediated disinhibition of dopamine neuron activity
in the ventral tegmental area (e.g., Kalivas et al. 1990;
Spanagel et al. 1992). We have previously shown that the
detrimental effects of psychostimulants on impulsivity in
the 5-CSRTT largely depend on dopamine receptor activa-
tion (Van Gaalen et al. 2006a). More specifically, previous
studies have pinpointed the nucleus accumbens (Cole and
Robbins 1989; Murphy et al. 2008) and in particular
dopamine within this brain region as critical (Cole and
Robbins 1987; Pattij et al. 2007b). Thus, increments in
accumbal dopamine transmission might explain the effects
of morphine on inhibitory control in the 5-CSRTT.
Alternatively, altered dopamine function in the prefrontal
cortex has been related to impulse action in the 5-CSRTT
(Dalley et al. 2002). Nonetheless, doses of morphine that
elevate extracellular dopamine in the nucleus accumbens
were ineffective in altering dopamine in the prefrontal
cortex (Bassareo et al. 1996). Furthermore, other basal
ganglia and connected nuclei, such as the subthalamic
nucleus (Baunez and Robbins 1997) and pedunculopontine
tegmental nucleus (Inglis et al. 2001), have been implicated
in impulsivity in the 5-CSRTT. To our knowledge, no
studies have directly examined (1) dopaminergic modula-
tion of impulsive action or (2) opioid modulation of
dopamine transmission within these nuclei. Taken together,
future work should elucidate whether altered dopamine
transmission and which specific brain regions are critically
involved in morphine-induced impulsivity.
Whether opioid modulation of mesolimbic dopamine
transmission is responsible for the decrease in preference
for the large over small reward induced by morphine also
remains a topic for further experiments. Given previous
data, this seems an unlikely explanation. In contrast to the
aforementioned detrimental effects of elevating dopamine
transmission on impulsive action, in general, elevating
dopamine transmission results in more self-controlled
decisions in rodent delayed reward paradigms (Cardinal
et al. 2000; Isles et al. 2003; Van Gaalen et al. 2006b;
Wade et al. 2000; Winstanley et al. 2005; for review, Pattij
and Vanderschuren 2008) and in healthy volunteers (De Wit
et al. 2002).
Alternatively, acute challenges with morphine at doses
of 5 mg/kg have been demonstrated to reduce extracel-
lular levels of noradrenaline in the prefrontal cortex
(Devoto et al. 2002; Rossetti et al. 1993), presumably
mediated via presynaptic µ-opioid receptors on noradren-
ergic nerve terminals in the cortex (Mulder et al. 1987). Yet,
to our knowledge, no evidence is available unequivocally
demonstrating a role for cortical noradrenaline in impulsive
choice. However, the α2 adrenoceptor agonist clonidine
induces impulsive choice in the delayed reward paradigm
(Van Gaalen et al. 2006b). Presumably, this effect is
mediated through activation of presynaptic α2 receptors,
which in turn strongly inhibits noradrenergic neurotrans-
mission (Starke 2001). Furthermore, recent findings dem-
onstrate that increasing noradrenaline transmission by the
selective noradrenaline reuptake inhibitor atomoxetine
reduces impulsivity in the delayed reward paradigm
(Robinson et al. 2008), a finding that is possibly explained
by the effects of atomoxetine on cortical noradrenaline
transmission (Bymaster et al. 2002; Swanson et al. 2006).
Taken together, two conclusions can be drawn from
the present data. First, our findings provide evidence
that acute challenges with morphine impair measures of
inhibitory control. Second, in support of previous data
demonstrating acute morphine effects on impulsive
decision making (Kieres et al. 2004), our findings also
suggest acute opioid effects on this measure of impulsivity.
Accumulating evidence has now implicated impulsivity in the
vulnerability towards and maintenance of drug addiction (see
for reviews, Perry and Carroll 2008; Verdejo-Garcia et al.
2008). In view of this, an implication of our findings might
be that the acute effects of opiates on impulsivity partly
contribute to the persistence of opiate use.
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